Jones Financial Companies’s Trinity Biotech TRIB Stock Holding History

Jones Financial Companies’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31K	Sell	121 -6	-5%	-$111	﹤0.01%	4542
2026 Q1	$2.29K	Hold	127	–	–	﹤0.01%	4112
2025 Q4	$3.01K	Buy	127 +11	+9%	+$324	﹤0.01%	3698
2025 Q3	$3.71K	Hold	116	–	–	﹤0.01%	3480
2025 Q2	$2.26K	Buy	116 +100	+625%	+$2.01K	﹤0.01%	3428
2025 Q1	$300	Hold	16	–	–	﹤0.01%	3561
2024 Q4	$412	Hold	16	–	–	﹤0.01%	3252
2024 Q3	$510	Buy	16 +6	+60%	+$406	﹤0.01%	2890
2024 Q2	$656	Buy	+10	New	+$582	﹤0.01%	2321

Other funds holding TRIB

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's TRIB Position: Q2 2026 in Review

Jones Financial Companies reduced its Trinity Biotech (TRIB) stake by 4.7% in Q2 2026, selling an estimated $111 and leaving 121 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #4542.

Jones Financial Companies first reported a position in TRIB in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.71K in Q3 2025. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

Jones Financial Companies held 121 shares of Trinity Biotech worth $1.31K as of Q2 2026.
Jones Financial Companies sold 6 Trinity Biotech shares in Q2 2026, an estimated $111.
Trinity Biotech made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4542 holding.
Jones Financial Companies first reported a position in Trinity Biotech in Q2 2024 and has held it in 9 quarters since.
Jones Financial Companies's Trinity Biotech position peaked at $3.71K in Q3 2025.
19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.